Literature DB >> 9327987

Catecholamines in the central nervous system. Overview.

A A Grace1, C R Gerfen, G Aston-Jones.   

Abstract

A goal of this part is to examine the functional impact of catecholaminergic systems on CNS function as it relates to normal and pathological states. The participants achieve their objectives individually by relating their high-quality work on this expansive topic, while maintaining a focus on the functional implications of their findings. Nonetheless, despite the necessarily broad nature of the topics presented, there is a remarkable degree of convergence of information. Several subthemes have emerged as a consequence of considering this work in its entirety. First is the importance of examining neurotransmitter effects, not in isolation, but in terms of interactions with other neurotransmitter systems. History has shown that a limited focus often produces confusing or inconsistent results, which become increasingly clear on consideration of the state of the organism. Second is the importance of examining pharmacological and pathophysiological interactions in light of the anatomy of the system and how developmental influences can alter this relationship. Such very general considerations have been found to provide an essential ingredient in understanding the nature of catecholamine function within this complex system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9327987     DOI: 10.1016/s1054-3589(08)60836-4

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN: 1054-3589


  14 in total

Review 1.  Neurochemistry and defects of biogenic amine neurotransmitter metabolism.

Authors:  K Hyland
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

Review 2.  Strategies to unravel molecular codes essential for the development of meso-diencephalic dopaminergic neurons.

Authors:  F M J Jacobs; S M Smits; K J M Hornman; J P H Burbach; M P Smidt
Journal:  J Physiol       Date:  2006-06-29       Impact factor: 5.182

3.  Nonlinear dose-dependent impact of D1 receptor activation on motor cortex plasticity in humans.

Authors:  Shane Fresnoza; Walter Paulus; Michael A Nitsche; Min-Fang Kuo
Journal:  J Neurosci       Date:  2014-02-12       Impact factor: 6.167

Review 4.  Recent Trends in the Quantification of Biogenic Amines in Biofluids as Biomarkers of Various Disorders: A Review.

Authors:  Alina Plenis; Ilona Olędzka; Piotr Kowalski; Natalia Miękus; Tomasz Bączek
Journal:  J Clin Med       Date:  2019-05-09       Impact factor: 4.241

Review 5.  Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology.

Authors:  J F Cubells; C P Zabetian
Journal:  Psychopharmacology (Berl)       Date:  2004-04-16       Impact factor: 4.530

6.  Differential regulation of action potential- and metabotropic glutamate receptor-induced Ca2+ signals by inositol 1,4,5-trisphosphate in dopaminergic neurons.

Authors:  Guohong Cui; Brian E Bernier; Mark T Harnett; Hitoshi Morikawa
Journal:  J Neurosci       Date:  2007-04-25       Impact factor: 6.167

7.  Synergistic effects between CA1 mu opioid and dopamine D1-like receptors in impaired passive avoidance performance induced by hepatic encephalopathy in mice.

Authors:  Mohammad Nasehi; Samaneh Amin Yavari; Mohammad Reza Zarrindast
Journal:  Psychopharmacology (Berl)       Date:  2013-02-13       Impact factor: 4.530

8.  Altered neurotensin mrna expression in mice lacking the dopamine transporter.

Authors:  C Roubert; C Spielewoy; P Soubrié; M Hamon; B Giros; C Betancur
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

9.  Crucial role of zebrafish prox1 in hypothalamic catecholaminergic neurons development.

Authors:  Anna Pistocchi; Germano Gaudenzi; Silvia Carra; Erica Bresciani; Luca Del Giacco; Franco Cotelli
Journal:  BMC Dev Biol       Date:  2008-03-10       Impact factor: 1.978

10.  Differential regulation of the zebrafish orthopedia 1 gene during fate determination of diencephalic neurons.

Authors:  Luca Del Giacco; Paolo Sordino; Anna Pistocchi; Nikos Andreakis; Raffaella Tarallo; Barbara Di Benedetto; Franco Cotelli
Journal:  BMC Dev Biol       Date:  2006-10-30       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.